Biogen Alzheimer's drug exceeds expectations
March 20, 2015 at 05:35 AM EDT
A Biogen Alzheimer's drug showed reductions in levels of the amyloid plaques and a significant slowing of the disease's hallmark cognitive declines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|